Lactic acid bacteria, hypoglycemic agents derived from lactic acid bacteria, drugs for treating diabetes, and food and drink

摘要

The lactic acid bacterium according to the present invention is lactic acid bacteria belonging to the genus enteroccocci, which is the Nccd No. n2309, which is the acceptance number in the patent microorganism depositing Center (npmd) of the incorporated administrative agency (npmd).The lactic acid bacterium of the present invention has an. Alpha. - glycosidase inhibitory activity and suppresses the increase in blood sugar level by sucrose ingestion.The. Alpha. - glycosidase inhibitor and hypoglycemic agent of the present invention are characterized in that the lactic acid bacterium, the dead bacterium of the lactic acid bacterium or the treated substance of the lactic acid bacterium are effective components